All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date, and reported results||2017-000347-41||Safety of extended use of the weekly oral docetaxel formulation ModraDoc006/r in patients with advanced solid tumours Veiligheid van voortgaand gebruik van de wekelijkse orale docetaxel formulerin...||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2018-003249-41||A multicentre phase IIa study to evaluate the efficacy and tolerability of ModraDoc006/r in patients with recurrent or metastatic HER-2 negative breast cancer, suitable for treatment with a taxane||2020-11-09||bad-data|
|Reported results||2019-000582-21||A multicentre Phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic Castration Resistant Prostate Cancer (mCRPC), suitable for treatment with a taxane.||2021-11-29||due-trials|